Abiopharma

New Form 8-K - Mersana Therapeutics, Inc. Filed: 2025-07-24 AccNo: 0001104659-25-070245 Size: 212 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13D/A - FARO TECHNOLOGIES INC Filed: 2025-07-24 AccNo: 0001104659-25-070242 Size: 28 KB

New Form 8-K - Bausch Health Companies Inc. Filed: 2025-07-24 AccNo: 0001193125-25-163860 Size: 155 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form SC TO-T/A - Verve Therapeutics, Inc. Filed: 2025-07-24 AccNo: 0001193125-25-163856 Size: 52 KB

New Form 8-K - Integer Holdings Corp Filed: 2025-07-24 AccNo: 0001171843-25-004663 Size: 634 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 424B3 - Azitra, Inc. Filed: 2025-07-24 AccNo: 0001493152-25-011367 Size: 465 KB

New Form 8-K - Semler Scientific, Inc. Filed: 2025-07-24 AccNo: 0001104659-25-070236 Size: 195 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events

New Form 8-K - Aditxt, Inc. Filed: 2025-07-24 AccNo: 0001213900-25-067130 Size: 310 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - ALTERITY THERAPEUTICS LTD Filed: 2025-07-24 AccNo: 0001213900-25-067132 Size: 53 KB

New Form DEF 14A - HYPERION DEFI, INC. Filed: 2025-07-24 AccNo: 0001104659-25-070234 Size: 3 MB